View Clinical Trial (Medical Research Study)

ADO II Clinical Study - NCT00713700-53226(Clinical Trial 381825)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Milwaukee
State:  
WI
Zip Code: 53226
Conditions: Patent Ductus Arteriosus
Purpose: The objective of this study is to investigate the safety and effectiveness of the ADO II in patients with a PDA.
Study summary:
Criteria: Inclusion Criteria: - Subject must have diagnosis of a PDA - Subject must have a PDA < 5.5mm in diameter by angiography - Subject must have a PDA < 12mm in length by angiography - Subject must have a PDA > 3mm in length by angiography - Subject/legally authorized representative must give consent to participate in the clinical study - Subject/legally authorized representative must consent to follow-up for the duration of the clinical study Exclusion Criteria: - Subject must not be < 6 kilograms for the procedure - Subject must not be < 6 months of age - Subject must not be ≥ 18 years of age - Subject must not have a descending aorta < 10mm in diameter - Subject must not have a right to left shunt through the patent ductus arteriosus - Subject must not have PVR above 8 Woods units or a Rp/Rs >0.4 - Subject must not have intracardiac thrombus - Subject must not have additional cardiac anomalies requiring surgical or interventional correction - Subject must not have history of more than two lower respiratory infections within the last year (i.e., pneumonia) - Subject must not have active infection requiring treatment at the time of implant - Subject must not have contraindication to anticoagulation treatment - Female subjects of child bearing age must not be pregnant or desire to become pregnant within six months post implant* - Subject must not be participating in another study for an investigational drug and/or device that may clinically interfere with this study's endpoints - If the subject desires to become pregnant after six months post-implant, further restriction is at the discretion of their physician.
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: May 21, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.